Does phenylalanine work without UVA?

There is no good evidence that it does. Every positive result in the literature pairs it with UVA exposure.

How long until repigmentation appears?

Published courses ran four to six months. Early change usually shows as pigment dots around hair follicles.

Which areas respond best?

Face and neck respond most often. Hands, feet and areas over bone respond poorly.

Is it safe in phenylketonuria?

No. Supplemental phenylalanine is contraindicated in PKU without exception.

Will the pigment stay if I stop?

Relapse is common when treatment stops, and maintenance phototherapy is often needed.

Can I use a home UV lamp?

Not advisable. Unmonitored UVA dosing causes burns and adds to lifetime skin cancer risk without a record of cumulative exposure.

Condition

Moderate Evidence

Effectiveness 3/5

L-Phenylalanine for Vitiligo

This is the one L-phenylalanine indication with real supporting trials. Taken before UVA light exposure, it improved repigmentation rates in vitiligo across several controlled European studies, particularly on the face. The critical qualifier is that the effect belongs to the combination — phenylalanine without phototherapy is not an effective vitiligo treatment.

Overview

L-phenylalanine for vitiligo is an adjunct to phototherapy, not a standalone supplement. Every meaningful result in the literature comes from combining oral or topical phenylalanine with UVA exposure, and the outcome measured is repigmentation of depigmented patches, chiefly on the face and neck. Response is partial and slow. Studies report cosmetically useful repigmentation in a minority to around half of treated patients over several months, with hands, feet and areas over bone responding worst.

The evidence base is old and thin: one small randomised trial from 1994 and two observational series, one of which reports six years of clinic experience. There is no modern replication, no standard product, and no agreement on optimal dosing. That is why the verdict sits at likely with clear caveats. It is best considered a dermatologist-supervised option, since the UVA component carries its own risk and needs proper dosimetry.

How It Works

Phenylalanine is the dietary precursor of tyrosine, which tyrosinase converts to DOPA and then to melanin. Supplying extra substrate is proposed to raise melanocyte precursor availability in follicular reservoirs that survive within depigmented skin. UVA is the necessary partner: it stimulates the surviving perifollicular melanocytes to proliferate and migrate outward, which is why repigmentation typically appears first as small dots around hair follicles.

A second proposed contribution is immunological. Vitiligo involves autoimmune destruction of melanocytes, and UVA has local immunosuppressive effects that reduce cytotoxic pressure on the remaining cells. Phenylalanine has also been suggested to blunt the antibody response implicated in melanocyte loss, but that evidence is weak and should be treated as hypothesis rather than established mechanism.

Dosing & Protocol

Published regimens use 50 to 100 mg/kg body weight of oral L-phenylalanine taken 30 to 45 minutes before UVA exposure, typically two to three sessions per week. A 10 percent phenylalanine gel applied to the patches before exposure was used in several series, alone or with the oral dose. Treatment courses ran for four to six months before response was judged. Shorter trials are uninformative because follicular repigmentation is inherently slow.

Absolute contraindication

People with phenylketonuria must never take supplemental phenylalanine. Anyone with a history of melanoma or photosensitising medication should not undertake UVA therapy.

Evidence

Three studies underpin this pairing: a 1994 randomised trial in Dermatology combining L-phenylalanine with UVA, a 1999 Archives of Dermatology report covering six years of oral and topical use, and a 1985 series in Archives of Dermatological Research that first described the combination. All are small, mostly uncontrolled, and predate modern vitiligo outcome scoring. They point consistently in one direction but cannot establish effect size with confidence.

Studies linked to this pairing.

Treatment of vitiligo with oral and topical phenylalanine: 6 years of experience

Score: 4/10

1999

observational

n=149

Camacho F, Mazuecos J

Oral and topical phenylalanine with light exposure produced repigmentation in most vitiligo patients over six years of practice.

View source

L-phenylalanine and UVA irradiation in the treatment of vitiligo

Score: 5/10

1994

rct

n=32

Siddiqui AH, Stolk LM, Bhaggoe R

L-phenylalanine with UVA produced significantly greater facial repigmentation than UVA alone.

View source

Phenylalanine and UVA light for the treatment of vitiligo

Score: 3/10

1985

observational

n=149

Cormane RH, Siddiqui AH, Westerhof W

Phenylalanine combined with UVA exposure produced repigmentation in a majority of treated vitiligo patients.

View source

Safety

Oral phenylalanine at these doses was generally tolerated in the published series, with nausea and mild gastrointestinal upset the usual complaints. Reported adverse events were mostly attributable to the UVA component: erythema, itching and phototoxic burn. Cumulative UVA exposure carries long-term photoageing and skin cancer risk, which is the main reason this should be run through a dermatology service that tracks lifetime dose.

Not for pregnancy or PKU

Avoid in pregnancy and breastfeeding, in phenylketonuria and maternal PKU, and in anyone taking MAO inhibitors.

Interactions & Conflicts

The clearest conflict is with MAO inhibitors, where large amino acid loads can contribute to hypertensive reactions. Phenylalanine also competes with levodopa for the same transport system across the gut wall and blood-brain barrier, which can reduce Parkinson medication effectiveness. Separately, any photosensitising drug taken alongside UVA raises burn risk sharply and should be reviewed before starting.

Severity	Mechanism	Action
high	—	—
high	—	—
high	—	—
moderate	—	—

References

Frequently Asked Questions

Medical Disclaimer

The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.